企业档案
会员类型：标准版
已获得阿仪网信誉 等级评定
(0 -40)基础信誉积累，可浏览访问
(41-90)良好信誉积累，可接洽商谈
(91+ )优质信誉积累，可持续信赖
阿仪网标准版会员：8年
工商认证 【已认证】
最后认证时间：无需年检
注册号：**** 【已认证】
法人代表：谭春** 【已认证】
参观次数：2676310
技术文章
文献引用产品：大鼠胃蛋白酶（PP）Elisa试剂盒
点击次数：14 发布时间：2026/10/15 14:32:42
文章标题：Yiqi Jiedu Huayu decoction inhibits precancerous lesions of chronic atrophic gastritis by inhibiting NLRP3 inflammasome-mediated pyroptosis
作者列表：Peng Zhou, Zi-Han Zheng, Tao Wan, Chuan-Wen Liao, Jie Wu
影响因子：2.5
期刊：World Journal of Gastrointestinal Oncology
发表时间：2024-7-15
DOI:10.4251/wjgo.v16.i7.3158
文献主题：Abstract
BACKGROUND
Chronic atrophic gastritis (CAG) is a prevalent chronic gastritis usually accompanied by precancerous lesions such as intestinal ｍmbedplasia and dysplasia. The increasing application of traditional Chinese medicine in CAG treatment has shown promising results with low side effects and significant efficacy.
AIM
To investigate the pharmacological effects of Yiqi Jiedu Huayu decoction (YJHD) on precancerous lesions of CAG.
METHODS
A CAG rat model was established by Helicobacter pylori bacteria solution combined with N-methyl-N’-nitro-N-nitrosoguanidine. Histopathological measurements were conducted by hematoxylin-eosin and alcian blue and periodic acid-Schiff staining. Serum levels of inflammatory factors and gastric mucosal-related factors were examined using enzyme-linked immunosorbent assay. Protein and mRNA levels were quantified via western blot and quantitative real-time polymerase chain reaction analysis, respectively. Molecular interaction was verified by chromatin immunoprecipitation (ChIP) assay.
原创作者：上海雅吉生物科技有限公司
